Reducing lung function decline in patients with idiopathic pulmonary fibrosis: potential of nintedanib
Hannah V Woodcock,1,2 Philip L Molyneaux,1,3 Toby M Maher1–31Interstitial Lung Disease Unit, Royal Brompton Hospital, 2Centre for Respiratory Research, University College London, 3National Heart and Lung Institute, Imperial College London, London, UKAbstract: Idiopathic pulmonary fibrosis...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2013-06-01
|
| Series: | Drug Design, Development and Therapy |
| Online Access: | http://www.dovepress.com/reducing-lung-function-decline-in-patients-with-idiopathic-pulmonary-f-a13406 |